The guidelines for the use of short-term dual antiplatelet therapy (DAPT) after coronary intervention vary depending on the patient’s clinical situation and the type of intervention performed. In this touchCARDIO interview, we speak with Prof. Hyo-Soo Kim (Department of Internal Medicine, Seoul National University Hospital, Seoul, South Korea) to discuss the current guidelines for the use of short-term DAPT after percutaneous coronary intervention and the current unmet needs.
The abstract entitled ‘Comparison Of 3-month Versus 12-month Dual Antiplatelet Therapy After Coronary Intervention Using The Contemporary Drug-eluting Stents With Ultrathin Struts And Advanced Polymer Technology: The Host-idea Randomized Clinical Trial‘ was presented at ACC.23 Together With WCC (ACC.23/WCC) in New Orleans, 4–6 March 2023
Interviews in this series:
Questions:
- What are the guidelines for the use of short-term dual antiplatelet therapy (DAPT) after percutaneous coronary intervention (PCI), and what are the current unmet needs? (0:05)
Disclosures: Hyo-Soo Kim has nothing to disclose in relation to this video.
Support: Interview and filming supported by Touch Medical Media. Interview conducted by Katey Gabrysch.
Filmed as a highlight of ACC 2023
Access more content on Heart Failure here
Transcript
